NAFLD mark: an accurate model based on microRNA-34 for diagnosis of non-alcoholic fatty liver disease patients

por Mohamed, Amal A., El-Demery, Ahmed, Al-Hussain, Eman, Mousa, Shroouk, Halim, Ahmed Abdel, Mostafa, Sahar M., Abdelghany, Reda S., Mahmoud, Seham M., Elkady, Mohammad A., Raafat, Khaled, Hassnine, Alshymaa A., Omran, Mohamed M.
Publicado 2021

The effect of high oral loading dose of cholecalciferol in non-alcoholic fatty liver disease patients. A randomized placebo controlled trial

por Mohamed, Amal Ahmed, Halim, Ahmed Abdel, Mohamed, Sahar, Mahmoud, Seham Mohamed, Bahgat Eldemiry, Eman Mohamed, Mohamed, Rasha Sobh, Shaheen, Mahmoud Maamoun, Naguib, Gina G., Muharram, Nashwa M., Khalil, Mona G., Saed, Salma, Ibrahim, Randa, Salah Seif, Ahmed, Kamal, Noha, Nasraldin, Karima, Abdelrahman, Ali Elsaid, El Borolossy, Radwa
Publicado 2023